[Non-invasive ventilation in patients with severe hypercapnic encephalopathy in a conventional hospital ward]

Arch Bronconeumol. 2002 Aug;38(8):372-5. doi: 10.1016/s0300-2896(02)75242-3.
[Article in Spanish]

Abstract

Objective: To report our experience with non-invasive ventilation (NIV) at two levels of pressure (Bi-PAP) on a general respiratory medicine ward with patients in hypercapnic impaired consciousness and/or coma who had not previously been in an intensive care unit (ICU).

Methods: This was a prospective study of 13 patients, mean age 81 years (65-96), treated with NIV through a face mask. Ten had chronic obstructive pulmonary disease, with a mean FEV1 in stable condition of 35.2 14.6%. Glasgow scores upon admission were >/= 7. Arterial gases were monitored until suspension of NIV.

Results: After NIV for a mean 19 5 h/day in the first 48 hours and later of 6 1 h/day until a total of 74 9 h, 9 patients (69%) survived. The mean initial pH for these patients was 7.17 0.028 and the mean initial pCO2 was 101 9 mm Hg. In 7 cases (78%), coma was reversed in the first 48 h and a significant improvement in pH was observed in the 12-24 h analysis. Mean pH upon discharge was 7.44 0.013 and mean pCO2 was 54 2.8 mmHg. Four patients died, even though their initial or subsequent arterial gases at 12-24 h were not significantly different from those of the survivors.

Conclusion: NIV on a general respiratory medicine ward can offer an alternative to oro-tracheal intubation for patients with hypercapnic impaired consciousness and/or coma who do not meet the criteria for admission to the ICU.

Publication types

  • Comparative Study
  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Carbon Dioxide / blood
  • Coma / therapy*
  • Consciousness Disorders / therapy*
  • Female
  • Humans
  • Hypercapnia / therapy*
  • Male
  • Masks
  • Positive-Pressure Respiration* / instrumentation
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Respiratory Care Units
  • Respiratory Function Tests
  • Respiratory Insufficiency / therapy*

Substances

  • Carbon Dioxide